Corcept Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.61 |
Market Cap |
$1.25 B |
Shares Outstanding |
114.86 M |
Public Float |
103.46 M |
Address |
149 Commonwealth Drive Menlo Park California 94025 United States |
Employees | - |
Website | http://www.corcept.com |
Updated | 07/08/2019 |
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. |